Shopping Cart
- Remove All
- Your shopping cart is currently empty
MRL-871 is a selective RORγt allosteric inhibitor, reducing IL-17a mRNA production in EL4 cells, interacting with PPARgamma in partial agonistic binding modes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $985 | In Stock | |
50 mg | $1,280 | In Stock | |
100 mg | $1,990 | In Stock |
Description | MRL-871 is a selective RORγt allosteric inhibitor, reducing IL-17a mRNA production in EL4 cells, interacting with PPARgamma in partial agonistic binding modes. |
Targets&IC50 | RORγt:264 nM |
In vitro | MRL-871 is a reverse agonist of retinoic acid-associated orphan receptor γt (RORγt) with a high affinity, KD value of 250 nM and IC50 of 264 nM. [1] |
Alias | MRL871 |
Molecular Weight | 444.79 |
Formula | C22H12ClF3N2O3 |
Cas No. | 1392809-08-3 |
Smiles | O=C(O)C=1C=CC(=CC1)C2=NN(C(=O)C=3C(Cl)=CC=CC3C(F)(F)F)C=4C=CC=CC24 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 15 mg/mL (33.72 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.